Formulation development and evaluation of bilayer tablets of sucralfate and amoxycillin for the effective treatment of ulcer
Abstract
Objective: The present research was carried out with the aim of developing bilayer tablets of sucralfate and amoxycillin for the effective treatment of ulcer.
Methods: Development of bilayer tablet of sucralfate and amoxycillin was carried out by the direct compression method. Finally it was optimized according to several evaluation parameters.
Results: Based on the cumulative dissolution studies of sucralfate and amoxcillin similarity factor and other physical evaluation studies, the IF8 and F8 formulation were present exhibited good properties of bilayer tablet formulation in terms of excipient proportion. Formulate instant release layer and control release layer individually passed the pre-compression tests that are angle of repose, bulk density, tapped bulk density, compressibility index, and hausner’s ratio. The instant release layer of released approx 99.89 percent of drug within 15 min and control release layer released approx 99.89 percent of drug up to 12 hrs.
Conclusion: Experiment concluded that bi-layer tablet is suitable for delivering same drugs with different release pattern like one layer of drug as immediate release to get quick relief from pain and second drug as sustained release of drug which gives effect of drug for sufficient long time and reduce frequency of dose.
Downloads
References
2. CN Kumar AB, Pandit HK, Singh SP , Design and evaluation sustained release bilayer tablets of propranolol hydrochloride, Acta Pharm 2007; 57: 479–489.
3. Uekama K. Matsubara K, Abe K, Horiuchi Y, Utility of beta cyclodextrin; Cellulose derivative combination as modified-release drug carrier. J Pharm Sc. 1990; 79: 244-248.
4. Wang Z. Horikawa T. Hirayama F, Uekama K. Design and in vitro evaluation of modified release oral dosage form of nifidifine. J. Pharm Pharmacol 1993; 45: 942-946.
5. Kumar A. Agrawal SP, Khanna R. Modified released bi-layered tablet of melatonin using betacyclodextrin. Phamazie 2003; 58: 642-644.
6. Yan G, Li H, Zhang R. Prepration and evaluation of a sustained –release formulation of nifedipine HPMC tablets. Drug Dev Ind Pharm 2000; 26: 681-686.
7. Fassihi RA, Ritschel WA. Multiple layer, direct compression controlled release system: In vitro and in vivo evaluation. J Pharm Sci 1993; 82: 750-754.
8. Lopes CM, José M, Lobo S, Pinto F, Costa PC. Compressed matrix core tablet as a quick/slow dual-component delivery system containing ibuprofen. AAPS Pharm SciTech 2007; 8: E1-E8.
9. Maggi L, Machiste EO, Torre ML, Conte U. Formulation of biphasic release tablets containing slightly soluble drugs. European J Pharma Biopharma 1998; 48: 37-42.
10. Billinghurst MW, Abrams DN, Lawson MS. Chemical aspects of labeling sucralfate with 99mTcO4. J NucI Med 1989: 30: 523-530.
11. Bauer-Brandl A, Becker D. Drug Dev. Ind. Pharm 1996; 22: 417-430.
12. Sheth BB, Bandelin FJ, Shangraw RF. Pharmaceutical dosage forms: Tablets, V-1, New York: Marcel Dekker Inc.1980.
13. Ansel HC, Popovich NG, Allen LV. Pharmaceutical dosage forms and drug delivery systems, Philadelphia: Lea & Febiger 1995.
14. Doelker E. Drug Dev Ind Pharm 1993; 19: 2399-2471.
15. Ferrero C, Munoz N, Velasco MV, Munoz-Ruiz A, Jiménez-Castellano SR. Int J Pharm 1997; 144: 11-21.
16. Lachman L, Lieberman HA, Joseph LK. The theory and practice of industrial pharmacy, Third edition 1990; 317-324.
Copyright © Author(s) retain the copyright of this article.

.